AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fresenius Medical Care AG & Co. KGaA

Transaction in Own Shares Feb 3, 2020

165_rns_2020-02-03_f1a2e7af-aa32-404e-8786-8691dc01d857.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

News Details

Other Capital Market Information | 3 February 2020 10:25

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052

03.02.2020 / 10:25

Dissemination of a Post-admission Duties announcement transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

– Share buy-back – 33 rd Interim Report

In the period from January 27, 2020 until and including January 31, 2020, a total of 4,398 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA (‘Fresenius Medical Care’) announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:

Day of repurchase Aggregated volume in number of shares Weighted average share price

in EUR
27.01.2020 0
28.01.2020 0
29.01.2020 0
30.01.2020 4,398 70.9566
31.01.2020 0

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including January 31, 2020 therefore amounts to 5,232,076 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care’s website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA

represented by Fresenius Medical Care Management AG

represented by its Management Board

Bad Homburg v.d.H., February 3, 2020


03.02.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com
End of News DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.